SouthState Bank Corp Sells 2,883 Shares of UnitedHealth Group Incorporated $UNH

SouthState Bank Corp lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 50.5% during the first quarter, Holdings Channel reports. The fund owned 2,823 shares of the healthcare conglomerate’s stock after selling 2,883 shares during the period. SouthState Bank Corp’s holdings in UnitedHealth Group were worth $764,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of UNH. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at about $4,376,167,000. T. Rowe Price Investment Management Inc. increased its stake in shares of UnitedHealth Group by 141.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock valued at $1,356,432,000 after purchasing an additional 2,410,128 shares during the last quarter. Cardano Risk Management B.V. lifted its holdings in shares of UnitedHealth Group by 864.4% in the fourth quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after acquiring an additional 2,262,006 shares during the last quarter. Hsbc Holdings PLC boosted its holdings in shares of UnitedHealth Group by 87.5% during the 4th quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate’s stock valued at $1,294,367,000 after acquiring an additional 1,826,948 shares in the last quarter. Finally, Lone Pine Capital LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at about $528,273,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $417.33 on Thursday. The stock has a market capitalization of $378.99 billion, a PE ratio of 31.52, a P/E/G ratio of 1.70 and a beta of 0.62. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The company’s 50 day simple moving average is $402.80 and its two-hundred day simple moving average is $341.04. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $434.30.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business’s quarterly revenue was up 2.0% on a year-over-year basis. During the same quarter last year, the company posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Analysts predict that UnitedHealth Group Incorporated will post 18.39 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 70.09%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.28% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Morgan Stanley lifted their target price on UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a report on Tuesday, June 30th. UBS Group lifted their price target on shares of UnitedHealth Group from $410.00 to $460.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday. Robert W. Baird lifted their price target on UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a research note on Wednesday, April 22nd. Finally, Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective on the stock in a report on Wednesday, April 22nd. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $429.50.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Truist raised its price target on UnitedHealth Group to $480 and maintained a buy rating, signaling confidence in further upside ahead of earnings. UnitedHealth Group (NYSE:UNH) Price Target Raised to $480.00 at Truist Financial
• Positive Sentiment: KeyCorp lifted its price target to $475 and kept an overweight rating, adding to the bullish analyst backdrop for UNH. UnitedHealth Group had its price target raised by KeyCorp from $400.00 to $475.00.
• Positive Sentiment: Zacks Research upgraded UnitedHealth to strong-buy and nudged up future EPS estimates, reinforcing expectations that the company can beat earnings again. UnitedHealth Group was upgraded by Zacks Research from hold to strong-buy.
• Positive Sentiment: Analysts have been raising earnings forecasts for UnitedHealth, and several reports argue the company has a strong chance to top Q2 expectations based on its historical surprise record and favorable earnings setup. Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: UNH is scheduled to report second-quarter results on July 16, so trading is being driven in part by positioning ahead of the earnings release. UnitedHealth Stock Forecast: Piper Sandler Analyst and Technical Indicators Point to Upside Ahead of Q2 Earnings
• Neutral Sentiment: Technical indicators and some market commentary suggest the stock may have room to move higher after earnings, but this is still contingent on the actual results and outlook. UnitedHealth Reports Earnings Thursday. Here’s How Much Its Stock Is Seen Moving
• Negative Sentiment: Broader managed-care stocks sold off after Elevance Health highlighted margin pressure and weak Medicaid-spending trends, which could weigh on sentiment toward UnitedHealth ahead of its report. Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.